|
1
|
Siegel RL, Miller KD, Fuchs HE and Jemal
A: Cancer statistics, 2022. CA Cancer J Clin. 72:7–33. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Dekker E, Tanis PJ, Vleugels JLA, Kasi PM
and Wallace MB: Colorectal cancer. Lancet. 394:1467–1480. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Micic J, Li Y, Wu S, Wilson D, Tutuncuoglu
B, Gao N and Woolford JL Jr: Coupling of 5S RNP rotation with
maturation of functional centers during large ribosomal subunit
assembly. Nat Commun. 11:37512020. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Castillo Duque de Estrada NM, Thoms M,
Flemming D, Hammaren HM, Buschauer R, Ameismeier M, Baßler J, Beck
M, Beckmann R and Hurt E: Structure of nascent 5S RNPs at the
crossroad between ribosome assembly and MDM2-p53 pathways. Nat
Struct Mol Biol. 30:1119–1131. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Li H, Hu X, Cheng C, Lu M, Huang L, Dou H,
Zhang Y and Wang T: Ribosome production factor 2 homolog promotes
migration and invasion of colorectal cancer cells by inducing
epithelial-mesenchymal transition via AKT/Gsk-3β signaling pathway.
Biochem Biophys Res Commun. 597:52–57. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Qu S, Huang X, Guo X, Zheng Z, Wei T and
Chen B: Metastasis related epithelial-mesenchymal transition
signature predicts prognosis and response to chemotherapy in acute
myeloid leukemia. Drug Des Devel Ther. 17:1651–1663. 2023.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Gelatti ACZ, Drilon A and Santini FC:
Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in
epidermal growth factor receptor (EGFR) mutation-positive non-small
cell lung cancer (NSCLC). Lung Cancer. 137:113–122. 2019.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang J, Li H and Ren G:
Epithelial-mesenchymal transition and drug resistance in breast
cancer (review). Int J Oncol. 47:840–848. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Uramoto H, Shimokawa H, Hanagiri T, Kuwano
M and Ono M: Expression of selected gene for acquired drug
resistance to EGFR-TKI in lung adenocarcinoma. Lung Cancer.
73:361–365. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Arumugam T, Ramachandran V, Fournier KF,
Wang H, Marquis L, Abbruzzese JL, Gallick GE, Logsdon CD, McConkey
DJ and Choi W: Epithelial to mesenchymal transition contributes to
drug resistance in pancreatic cancer. Cancer Res. 69:5820–5828.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
McConkey DJ, Choi W, Marquis L, Martin F,
Williams MB, Shah J, Svatek R, Das A, Adam L, Kamat A, et al: Role
of epithelial-to-mesenchymal transition (EMT) in drug sensitivity
and metastasis in bladder cancer. Cancer Metastasis Rev.
28:335–344. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li S, Zhang W, Yin X, Xing S, Xie HQ, Cao
Z and Zhao B: Mouse ATP-binding cassette (ABC) transporters
conferring multi-drug resistance. Anticancer Agents Med Chem.
15:423–432. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhu Y, Huang S, Chen S, Chen J, Wang Z,
Wang Y and Zheng H: SOX2 promotes chemoresistance, cancer stem
cells properties, and epithelial-mesenchymal transition by
β-catenin and Beclin1/autophagy signaling in colorectal cancer.
Cell Death Dis. 12:4492021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang YJ, Zhang YK, Zhang GN, Al Rihani SB,
Wei MN, Gupta P, Zhang XY, Shukla S, Ambudkar SV, Kaddoumi A, et
al: Regorafenib overcomes chemotherapeutic multidrug resistance
mediated by ABCB1 transporter in colorectal cancer: In vitro and in
vivo study. Cancer Lett. 396:145–154. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ghosh S: Cisplatin: The first metal based
anticancer drug. Bioorg Chem. 88:1029252019. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
van Driel WJ, Koole SN, Sikorska K,
Schagen van Leeuwen JH, Schreuder HWR, Hermans RHM, de Hingh IHJT,
van der Velden J, Arts HJ, Massuger LFAG, et al: Hyperthermic
intraperitoneal chemotherapy in ovarian cancer. N Engl J Med.
378:230–240. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Jiang H, Tian H, Wang Z, Li B, Chen R, Luo
K, Lu S, Nice EC, Zhang W, Huang C, et al: Laser-activatable oxygen
self-supplying nanoplatform for efficiently overcoming colorectal
cancer resistance by enhanced ferroptosis and alleviated hypoxic
microenvironment. Biomater Res. 27:922023. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Cherkasova V, Ilnytskyy Y, Kovalchuk O and
Kovalchuk I: Transcriptome analysis of cisplatin, cannabidiol, and
intermittent serum starvation alone and in various combinations on
colorectal cancer cells. Int J Mol Sci. 24:147432023. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Kurien BT and Scofield RH: Western
blotting. Methods. 38:283–293. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Chen Z, Shi T, Zhang L, Zhu P, Deng M,
Huang C, Hu T, Jiang L and Li J: Mammalian drug efflux transporters
of the ATP binding cassette (ABC) family in multidrug resistance: A
review of the past decade. Cancer Lett. 370:153–164. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Paumi CM, Chuk M, Snider J, Stagljar I and
Michaelis S: ABC transporters in saccharomyces cerevisiae and their
interactors: New technology advances the biology of the ABCC (MRP)
subfamily. Microbiol Mol Biol Rev. 73:577–593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Porro A, Haber M, Diolaiti D, Iraci N,
Henderson M, Gherardi S, Valli E, Munoz MA, Xue C, Flemming C, et
al: Direct and coordinate regulation of ATP-binding cassette
transporter genes by Myc factors generates specific transcription
signatures that significant affect the chemoresistance phenotype of
cancer cells. J Biol Chem. 285:19532–19543. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Porro A, Iraci N, Soverini S, Diolaiti D,
Gherardi S, Terragna C, Durante S, Valli E, Kalebic T, Bernardoni
R, et al: c-MYC oncoprotein dictates transcriptional profiles of
ATP-binding cassette transporter genes in chronic myelogenous
leukemia CD34+ hematopoietic progenitor cells. Mol Cancer Res.
9:1054–1066. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Z, Xu Y, Meng X, Watari F, Liu H and
Chen X: Suppression of c-Myc is involved in multi-walled carbon
nanotubes' down-regulation of ATP-binding cassette transporters in
human colon adenocarcinoma cells. Toxicol Appl Pharmacol.
282:42–51. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Baluapuri A, Wolf E and Eilers M: Target
gene-independent functions of MYC oncoproteins. Nat Rev Mol Cell
Biol. 21:255–267. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Kleinschmidt MA, Streubel G, Samans B,
Krause M and Bauer UM: The protein arginine methyltransferases
CARM1 and PRMT1 cooperate in gene regulation. Nucleic Acids Res.
36:3202–3213. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Hsu WJ, Chen CH, Chang YC, Cheng CH, TsaI
YH and Lin CW: PRMT1 confers resistance to olaparib via modulating
MYC signaling in triple-negative breast cancer. J Pers Med.
11:10092021. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Eberhardt A, Hansen JN, Koster J, Lotta LT
Jr, Wang S, Livingstone E, Qian K, Valentijn LJ, Zheng YG, Schor NF
and Li X: Protein arginine methyltransferase 1 is a novel regulator
of MYCN in neuroblastoma. Oncotarget. 7:63629–63639. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Lu W, Yang C, He H and Liu H: The
CARM1-p300-c-Myc-Max (CPCM) transcriptional complex regulates the
expression of CUL4A/4B and affects the stability of CRL4 E3 ligases
in colorectal cancer. Int J Biol Sci. 16:1071–1085. 2020.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang J, Harnpicharnchai P, Jakovljevic J,
Tang L, Guo Y, Oeffinger M, Rout MP, Hiley SL, Hughes T and
Woolford JL Jr: Assembly factors Rpf2 and Rrs1 recruit 5S rRNA and
ribosomal proteins rpL5 and rpL11 into nascent ribosomes. Genes
Dev. 21:2580–2592. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Jaremko D, Ciganda M and Williams N:
Trypanosoma brucei homologue of regulator of ribosome synthesis 1
(Rrs1) Has direct interactions with essential trypanosome-specific
proteins. mSphere. 4:e00453–19. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Song J, Ma Z, Hua Y, Xu J, Li N, Ju C and
Hou L: Functional role of RRS1 in breast cancer cell proliferation.
J Cell Mol Med. 22:6304–6313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu XL, Yang ZW, He L, Dong PD, Hou MX,
Meng XK, Zhao HP, Wang ZY, Wang F, Baoluri, et al: RRS1 silencing
suppresses colorectal cancer cell proliferation and tumorigenesis
by inhibiting G2/M progression and angiogenesis. Oncotarget.
8:82968–82980. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Li HL, Dong LL, Jin MJ, Li QY, Wang X, Jia
MQ, Song J, Zhang SY and Yuan S: A review of the regulatory
mechanisms of N-myc on cell cycle. Molecules. 28:11412023.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Broso F, Gatto P, Sidarovich V, Ambrosini
C, De Sanctis V, Bertorelli R, Zaccheroni E, Ricci B, Destefanis E,
Longhi S, et al: Alpha-1 adrenergic antagonists sensitize
neuroblastoma to therapeutic differentiation. Cancer Res.
83:2733–2749. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Yu F, Mou B, Sheng J, Liu J, Qin X and Yu
J: DERL3 suppresses colorectal cancer metastasis through negatively
regulating MYCN level. Minerva Med. 114:316–322. 2023. View Article : Google Scholar : PubMed/NCBI
|
